Skip to main content
. 2020 Oct 27;11(43):3886–3899. doi: 10.18632/oncotarget.27778

Figure 2. The proportion of CEACAM5-positive tumors are significantly higher in non-TN breast cancer subtypes.

Figure 2

A bar graph showing the proportion of Luminal A, Luminal B, HER2-enriched and Triple-negative (TN) breast carcinomas positive for CEACAM5. *indicates p < 0.05 tested by ANOVA with Tukey’s significance test. Representative immunostained tumors are shown in top panel. Bar, 50 μm.